Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

1.4%

1 terminated/withdrawn out of 74 trials

Success Rate

93.3%

+6.8% vs industry average

Late-Stage Pipeline

7%

5 trials in Phase 3/4

Results Transparency

0%

0 of 14 completed trials have results

Key Signals

4 recruiting

Enrollment Performance

Analytics

N/A
37(63.8%)
Phase 1
10(17.2%)
Phase 2
6(10.3%)
Phase 3
3(5.2%)
Phase 4
2(3.4%)
58Total
N/A(37)
Phase 1(10)
Phase 2(6)
Phase 3(3)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (74)

Showing 20 of 74 trials
NCT07453420Active Not Recruiting

Profiling Vulnerability and Resilience for Mental Illness Following Viral Infections: Translating Epidemiology to Deep-phenotyping.

Role: lead

NCT07455344Recruiting

Mechanisms and Outcomes of Children and Adolescent Psychotherapy

Role: lead

NCT07326124Phase 3Not Yet Recruiting

Stratification and Treatment in Early Psychosis Study -ASSIST

Role: collaborator

NCT06778564Phase 3Not Yet Recruiting

Stratification and Treatment in Early Psychosis Study - ENHANCE

Role: collaborator

NCT06908343Recruiting

Psychotherapy Expectations and Distress Among Mental Health Patients and Their Therapists.

Role: lead

NCT03566069Phase 2Active Not Recruiting

Intranasal Oxytocin as Enhancer of Psychotherapy Outcomes in Severe Mental Illness

Role: lead

NCT06348472Recruiting

The Predictive Role of Immune-inflammatory Biomarkers and Their Interaction With the Oxytocin System in Trauma-related Psychotherapy Responsiveness

Role: lead

NCT05432089Phase 2Recruiting

The Effects of Oxytocin Administration to Patients and Therapists on Physiological Synchronization

Role: lead

NCT06332066Phase 1Not Yet Recruiting

Oxytocin Administration to Therapists and Its Effects on Patient-perceived Attunement and Responsiveness

Role: lead

NCT05865288Phase 1Unknown

The Moderating Role of Baseline Oxytocin on Its Psychotherapy-facilitating Effects Among Patients With Eating Disorders

Role: lead

NCT02644629Phase 4Completed

Intra-nasal vs. Intra-venous Ketamine Administration

Role: lead

NCT04551027Not ApplicableUnknown

Assessing the Effect of Compensatory Cognitive Intervention Among People With Severe Mental Illness

Role: lead

NCT04314154Unknown

Using Clinical Process Indicators, Patient Reported Outcome Measures (PROMs), and Patient Reported Experience Measures (PREMs) to Improve the Quality and Continuity of Care for Psychiatric Patients

Role: lead

NCT04309045Not ApplicableUnknown

Assessment of Cost-effectiveness in Two Empirically-based Psychotherapies for Borderline Personality Disorder: A Randomized Controlled Trial

Role: lead

NCT04017676Not ApplicableUnknown

Optimizing the Resources of Psychotherapy as a Tool for Implementing the Mental Health Reform

Role: lead

NCT03813264Not ApplicableUnknown

Optimizing Outcomes of Dynamic Psychotherapy by the MATRIX: A Preliminary Study

Role: lead

NCT03788902Not ApplicableCompleted

OT and Social Cognition in Children With ADHD: Impact of MPH

Role: lead

NCT03608449Not ApplicableUnknown

Doing More With Less": Optimizing Psychotherapeutic Services in the Mental Health System

Role: lead

NCT03541707Not ApplicableUnknown

Evaluation of the H1-Coil TMS- Double Blind Placebo Controlled Study in Adolescent Patients Suffering From Major Depression

Role: lead

NCT01754532Completed

Correlation Between Clinical Deterioration in Schizophrenic Patients and Hair Cortisol Levels

Role: lead